|
Topical DHEA Inhibits Tumors |
|
DHEA and Thermal Skin Injury |
|
High Bioavailability of DHEA |
|
Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans |
|
Replacement of DHEA in aging men and women-Potential remedial effects |
|
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age |
|
DHEA's Effects on Weight |
|
Anti-Obesity Properties of DHEA |
|
DHEA And Lipids |
|
DHEA's Effects on Weight |
|
Anti-Obesity Properties of DHEA |
|
DHEa and Lipids |
|
Does DHEA supplementation affect muscle mass? |
|
Androgens and the menopause; a study of 40-60-year-old women |
|
Adrenal and gonadal steroid hormone deficiency in the etiopathogenesis of rheumatoid arthritis |
|
Changes in circulating steroids with aging in postmenopausal women |
|
The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women |
|
Catabolic effects and the influence on hormonal variables under treatment with Gynodian-Depot (Reg.trademark) or dehydroepiandrosterone (DHEA) oenanthate |
|
Regulation of the immune response by dehydroepiandrosterone and its metabolites |
|
Stress-induced suppression of the cellular immune reactions: On the neuroendocrine control of the immune system |
|
Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. |
|
Replacement of DHEA in aging men and women. Potential remedial effects. |
|
Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. |
|
Dehydroepiandrosterone modulates the spontaneous and IL-6 stimulated fibrinogen production of human hepatoma cells. |
|
Administration of dehydroepiandrosterone reverses the immune suppression induced by high dose antigen in mice. |
|
Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum. |
|
Relationship between dehydroepiandrosterone and calcitonin gene-related peptide in the mouse thymus. |
|
Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. |
|
Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. |
|
In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. |
|
Immune senescence and adrenal steroids: immune dysregulation and the action of dehydroepiandrosterone (DHEA) in old animals. |
|
Effects of dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. |
|
Dehydroepiandrosterone protects mice inoculated with West Nile virus and exposed to cold stress. |
|
The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. |
|
Mobilization of cutaneous immunity for systemic protection against infections. |
|
Dehydroepiandrosterone-induced reduction of Cryptosporidium parvum infections in aged Syrian golden hamsters. |
|
Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. |
|
Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. |
|
Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. |
|
Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). |
|
Food intake reduction and immunologic alterations in mice fed dehydroepiandrosterone. |
|
Steroid induction of gonadotropin surges in the immature rat. I. Priming effects of androgens. |
|
Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro |
|
Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA |
|
Evidence for changes in adrenal and testicular steroids during HIV infection |
|
Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men |
|
Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499 |
|
Adrenal puberty or adrenarche |
|
Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells |
|
Chemoprevention by dietary dehydroepiandrosterone against promotion/progressi on phase of radiation-induced mammary tumorigenesis in rats |
|
Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat |
|
Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3beta,17beta-diol to risk of breast cancer in postmenopausal women |
|
DHEA: a hormone with multiple effects. |
|
Androgen replacement therapy in women: myths and realities. |
|
Aromatase in bone cell: Association with osteoporosis in postmenopausal women |
|
3beta-hydroxysteroid dehydrogenase/isomerase and aromatase activity in primary cultures of developing zebra finch telencephalon: Dehydroepiandrosterone as substrate for synthesis of androstenedione and estrogens |
|
Abnormal production of androgens in women with breast cancer |
|
Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line |
|
Dehydroepiandrosterone and diseases of aging |
|
Case report: amelioration of insulin resistance in diabetes with dehydroepiandrosterone. |
|
Therapeutic effects of dehydroepiandrosterone metabolites in diabetes mutant mice (C57BL/KsJ-db/db). |
|
Diabetes and adrenal disease. |
|
Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. |
|
[Isolated gonadotropin deficiency and secretory discrepancy of cortisol and adrenal androgen by hemochromatosis secondary to congenital dyserythropoietic anemia] |
|
Enhanced adrenocortical activity as a contributing factor to diabetes in hyperandrogenic women. |
|
Adrenal steroid and adrenocorticotropin responses to human corticotropin-releasing hormone stimulation test in adolescents with type I diabetes mellitus. |
|
[Dehydroepiandrosterone. Renaissance after 13 years] |
|
The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia. |
|
Therapeutic effects of dehydroepiandrosterone (DHEA) and its metabolites in obese-hyperglycemic mutant mice. |
|
Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone. |
|
Androgenic and estrogenic metabolites in serum of mice fed dehydroepiandrosterone: relationship to antihyperglycemic effects. |
|
Antiobesity effects of etiocholanolones in diabetes (db), viable yellow (Avy), and normal mice. |
|
Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. |
|
Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. |
|
Plasma androgen concentrations in diabetic women. |
|
The connective tissue diseases and the overall influence of gender |
|
Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE) |
|
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. |
|
Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha. |
|
Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. |
|
Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells |
|
Dehydroepiandrosterone (DHEA) increases production and release of Alzheimer's amyloid precursor protein. |
|
[Change of serum amyloid P component concentrations in women] |
|
Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia. |
|
Natural products and their derivatives as cancer chemopreventive agents |
|
New agents for cancer chemoprevention |
|
Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect. |
|
Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism |
|
Dehydroepiandrosterone sulphate as a source of steroids in menopause |
|
Relationship between sex steroid hormone levels and CD4 lymphocytes in HIV infected men |
|
Urinary steroids at time of surgery in postmenopausal women with breast cancer |
|
Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women |
|
Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects: The Wisconsin Epidemiologic Study of Diabetic Retinopathy |
|
Differences in substrate metabolism between self-perceived 'large-eating' and 'small-eating' women. |
|
Differential expression of hepatic oestrogen, phenol and dehydroepiandrosterone sulphotransferases in genetically obese diabetic (ob/ob) male and female mice. |
|
Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. |
|
Obesity, body fat distribution and sex hormones in men. |
|
Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. |
|
Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal women. |
|
Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus |
|
Increased testosterone in type I diabetic subjects with severe retinopathy. |
|
Increase in plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A. |
|
Peculiarities of the endocrine time structure in noninsulin-dependent adult-onset (type II) diabetes mellitus. |
|
Circadian time structure of endocrine and biochemical parameters in adult onset (type II) diabetic patients. |
|
Amniotic fluid beta-endorphin and beta-lipotropin concentrations during the second and third trimesters. |
|
Androgen and progesterone levels in females with rheumatoid arthritis |
|
Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphigoid/pemphigus and psoriasis |
|
Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production. |
|
The neurosteroid dehydroepiandrosterone sulfate (DHEAS) enhances hippocampal primed burst, but not long-term, potentiation. |